Yuyu Pharma Inc (000227) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.006x

Based on the latest financial reports, Yuyu Pharma Inc (000227) has a cash flow conversion efficiency ratio of 0.006x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩836.62 Million ≈ $566.97K USD) by net assets (₩139.10 Billion ≈ $94.26 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Yuyu Pharma Inc for the company's overall valuation and market capitalisation.

Yuyu Pharma Inc - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Yuyu Pharma Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Yuyu Pharma Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yuyu Pharma Inc ranked by their cash flow conversion efficiency. Explore 000227 cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
B&M European Value Retail SA LSE:BME	0.576x
Tong-Hwa Synthetic Fiber Co Ltd TW:1418	-0.051x
IFCA MSC Bhd KLSE:0023	-0.058x
Urban One Inc Class D NASDAQ:UONEK	-0.002x
Apollomics Inc. Class A Ordinary Shares NASDAQ:APLM	4.001x
SBF AG F:CY1K	N/A
Tate & Lyle PLC LSE:TATE	0.074x
Next Science Ltd AU:NXS	2.498x

Annual Cash Flow Conversion Efficiency for Yuyu Pharma Inc (2014–2024)

The table below shows the annual cash flow conversion efficiency of Yuyu Pharma Inc from 2014 to 2024. View 000227 stock price and chart for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩135.06 Billion ≈ $91.53 Million	₩24.95 Billion ≈ $16.91 Million	0.185x	+5182.83%
2023-12-31	₩120.36 Billion ≈ $81.56 Million	₩420.86 Million ≈ $285.21K	0.003x	+106.93%
2022-12-31	₩123.37 Billion ≈ $83.61 Million	₩-6.23 Billion ≈ $-4.22 Million	-0.050x	-244.10%
2021-12-31	₩128.69 Billion ≈ $87.21 Million	₩4.51 Billion ≈ $3.06 Million	0.035x	+253.64%
2020-12-31	₩117.04 Billion ≈ $79.31 Million	₩-2.67 Billion ≈ $-1.81 Million	-0.023x	-115.66%
2019-12-31	₩90.54 Billion ≈ $61.36 Million	₩13.19 Billion ≈ $8.94 Million	0.146x	+107.05%
2018-12-31	₩86.87 Billion ≈ $58.87 Million	₩6.11 Billion ≈ $4.14 Million	0.070x	+937.85%
2017-12-31	₩82.83 Billion ≈ $56.14 Million	₩561.35 Million ≈ $380.42K	0.007x	-94.60%
2016-12-31	₩78.29 Billion ≈ $53.06 Million	₩9.82 Billion ≈ $6.65 Million	0.125x	+179.12%
2015-12-31	₩73.73 Billion ≈ $49.97 Million	₩-11.68 Billion ≈ $-7.92 Million	-0.158x	-930.90%
2014-12-31	₩71.49 Billion ≈ $48.45 Million	₩1.36 Billion ≈ $923.95K	0.019x	--

About Yuyu Pharma Inc

KO:000227 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$30.10 Million

₩44.42 Billion KRW

Market Cap Rank

#23877 Global

#1655 in Korea

Share Price

₩7580.00

Change (1 day)

-0.92%

52-Week Range

₩6300.00 - ₩11670.00

All Time High

₩56262.57